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Abstract: Oviductal extracellular vesicles (oEVs) have been proposed as key modulators of
gamete/embryo maternal interactions. The aim of this study was to examine the metabolite content of
oEVs and its regulation across the estrous cycle in cattle. Oviductal EVs were isolated from bovine
oviducts ipsilateral and contralateral to ovulation at four stages of the estrous cycle (post-ovulatory
stage, early and late luteal phases, and pre-ovulatory stage). The metabolomic profiling of EVs was
performed by proton nuclear magnetic resonance spectroscopy (NMR). NMR identified 22 metabolites
in oEVs, among which 15 were quantified. Lactate, myoinositol, and glycine were the most abundant
metabolites throughout the estrous cycle. The side relative to ovulation had no effect on the oEVs’
metabolite concentrations. However, levels of glucose-1-phosphate and maltose were greatly affected
by the cycle stage, showing up to 100-fold higher levels at the luteal phase than at the peri-ovulatory
phases. In contrast, levels of methionine were significantly higher at peri-ovulatory phases than at the
late-luteal phase. Quantitative enrichment analyses of oEV-metabolites across the cycle evidenced
several significantly regulated metabolic pathways related to sucrose, glucose, and lactose metabolism.
This study provides the first metabolomic characterization of oEVs, increasing our understanding of
the potential role of oEVs in promoting fertilization and early embryo development.
Keywords: oviduct; fallopian tube; extracellular vesicles; exosomes; metabolomics; energy substrates;
amino acids; NMR
1. Introduction
Exosomes and microvesicles, collectively known as extracellular vesicles (EVs), are
membrane-enclosed particles able to transfer a complex selection of molecular compounds from
one cell to another, and in this way play key roles in cell-to-cell communications [1]. EVs have been
identified in all biological fluids and can be secreted by most cell types. In the female genital tract,
EVs have been isolated from follicular, uterine, and oviductal fluids (OF) [2–5]. EVs from the OF
(oEVs), also known as oviductosomes, have gained growing attention in recent years as they may
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act as natural cargos, bringing key components from the maternal compartment into gametes and
embryos for the establishment of pregnancy [5–9]. Oviductal EVs are released by oviductal epithelial
cells (OECs), as shown from in vitro studies [5,7], and may originate from the pre-ovulatory follicle at
ovulation. Previous studies in mice showed that incubation of spermatozoa with oEVs activates a Ca2+
eﬄux pomp, PMCA4, which is important for the acquisition of sperm hyperactivated motility and
fertilizing competence [6]. In the feline species, oEVs were shown to fuse with the sperm membrane, to
improve sperm motility and fertilizing ability, and to prevent premature acrosome reaction in vitro [8].
Recently, we showed that oEVs can reduce polyspermy during in vitro fertilization of pig oocytes
without affecting the global fertilization rate [10]. We also demonstrated that the co-incubation of
in vitro produced embryos with oEVs increased blastocyst rates, extended embryo survival over time,
and improved embryo quality [5]. In mice, oEVs from donor oviduct fluid in the transfer medium
were also shown to improve birth rates after the transfer of in vitro produced embryos to recipient
mothers [11]. All together, these data support the idea that oEVs play important roles in sperm
capacitation, fertilization, and early embryo development.
To further investigate the compounds carried by oEVs potentially playing these roles, we analyzed
the proteomic and transcriptomic profiles of oEVs across the estrus cycle revealing proteins, mRNAs,
and various types of small non-coding RNAs with important roles in early reproductive events [5,9].
To date, only a few studies have reported the molecular content of oEVs (reviewed in [12]). In the
present study, we focused on the metabolomic profile of oEVs, the least studied component of EVs
in all research areas, with still no available data on oEVs. If we consider that metabolites represent
an intermediate or end point of any cellular process, they can reflect the phenotype printout of a cell
at a specific moment. Thus, monitoring metabolic changes in any biological fluid under a variety
of physiological or pathological conditions may be seen as the goldmine of biomarkers of health
condition [13]. Moreover, determining the metabolite composition of EVs can reveal important aspects
in cell-to-cell communication.
On the other hand, it is widely accepted that the ovarian steroid hormones progesterone (P4)
and estradiol-17β (E2) regulate all components of the oviduct secretory activity [14] including oEV
content [9] and also influence the metabolic content of the OF [15]. Moreover, in mono-ovular species
like the bovine and human, the side of ovulation may also affect the molecular composition of the
proximal OF by topical hormonal regulations and putative input of the ovulatory follicle. Thus, the
objectives of the present study were to analyze the metabolomic profile of oEVs and examine whether
the oEV metabolite content is under the hormonal control of the estrous cycle and is dependent on the
side relative to ovulation.
2. Results
2.1. Characterization of Oviductal Extracellular Vesicles Used for Metabolomic Profiling
The oEVs samples collected from cyclic cows and used for NMR analysis are shown in Table 1.
Transmission electron microscopy (TEM) observation confirmed the presence of oEVs at the four
stages of cycle analyzed (Figure 1). Oviductal EVs samples contained a majority of vesicles resembling
exosomes (size of 30–100 nm; 76.4 ± 0.8%) and a small population of vesicles resembling microvesicles
(>100 up to 500 nm: 23.7 ± 0.8%), with similar proportions among stages, as we previously showed in
cattle [9]. Western blotting confirmed the expression of exosomal cytosolic markers (CD81, HSP70, and
ANXA1) in the oEV samples (Figure 1).
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Table 1. Samples of bovine oviductal extracellular vesicles (oEVs) used for proton nuclear magnetic
resonance spectroscopy (NMR) analysis.
Stage of the
Cycle No. Animals
1 Side Relative
to Ovulation
Number of OF
Pools
Volume (µL) of OF
before oEV Isolation
Protein Concentration
(mg mL−1)
Post-ovulatory 54
Ipsilateral 4 320–420 10.4–13.6
Contralateral 4 288–385 9.7–17.4
Mid-luteal 40
Ipsilateral 3 355–400 11.4–12.6
Contralateral 3 305–410 11.1–13.5
Late-luteal 34
Ipsilateral 3 315–470 9.4–10.3
Contralateral 3 350–470 13.1–15.9
Pre-ovulatory 40
Ipsilateral 3 450–495 10.0–15.2
Contralateral 3 500–580 12.0–13.4
1 Number of animals used to obtain 3–4 pools of oviductal fluid (OF) per stage × side with a minimum volume of
280 µL/pool that was used for oEV isolation.
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and analogues 
I Involved in biosynthesis of proteins 
Figure 1. Characterization of bovine oviductal extracellular vesicles (oEVs). Representative images of
exosomes (30–100 nm) and microvesicles (>100 nm) in oEV preparations observed by transmission
electron microscopy (TEM) across the estrus cycle (a) and Western blotting characterization of bovine
oEVs for known exosomal protein markers (b). A pool of samples from four different stages was used,
showing that oEVs were positive for CD81, HSP70, and ANXA1.
2.2. Metabolite Profile of oEVs across the Estrous Cycle
Proton nuclear magnetic resonance spectroscopy identified 22 metabolites in oEVs (Table 2). The
overall oEV metabolite composition showed various classes of metabolites including essential and
non-essential amino acids and various energy substrates among other categories (Table 2).
The concentrations of the 15 metabolites could be quantified (Table 3). Among the seven
metabolites that could not be quantified, five (glucose, glutamate, leucine, proline, and threonine) were
due to a large overlap of their signals with other metabolites and two (formate and ethanolamine) due
to signals below the detection threshold. From the 15 metabolites quantified, lactate, myo-inositol,
and glycine were the ost abundant metabolites throughout the estrous cycle, reaching on average
25–51.5 nmoL mg−1 of oEV protein.
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Table 2. Metabolites identified in bovine oviductal extracellular vesicles across the estrous cycle,
ordered by chemical classes 1.
Metabolite
Chemical Taxonomy
Subclass
Description
Identified
(I)/Quantified (Q) Function
Valine
Amino acids, peptides, and
analogues
(Proteinogenic)
Essential amino acids
I/Q Involved in stress, energy andmuscle metabolism
Threonine
Amino acids, peptides, and
analogues
(Proteinogenic)
Essential amino acids
I Involved in biosynthesis of proteins
Methionine
Amino acids, peptides, and
analogues
(Proteinogenic)
Essential amino acids
I/Q Required for normal growthand development
Leucine
Amino acids, peptides, and
analogues
(Proteinogenic)
Essential amino acids
I
Involved in biosynthesis of proteins, stress,
energy, and muscle metabolism.
Stimulates insulin release
Isoleucine
Amino acids, peptides, and
analogues
(Proteinogenic)
Essential amino acids
I/Q Involved in stress, energy andmuscle metabolism.
Proline
Amino acids, peptides, and
analogues
Conditionally essential
amino acids
(Proteinogenic)
I Involved in biosynthesis of proteins
Glycine
Amino acids, peptides, and
analogues
Non-essential amino acids
(Proteinogenic)
I/Q
Involved in the body’s production of DNA,
phospholipids, and collagen, and in release
of energy.
Alanine
Amino acids, peptides, and
analogues
Non-essential amino acids
(Proteinogenic)
I/Q
One of the most important amino acids
released by muscle, functioning as a major
energy source. Regulator of glucose
metabolism, lymphocyte reproduction
and immunity.
Glutamate
Amino acids, peptides, and
analogues
(Non-essential alpha Amino
Acids)
I
Involved in biosynthesis of proteins
Role as neurotransmitter, a chemical used
by nerve cells to send signals to other cells.
Creatine
Amino acids, peptides, and
analogues
(endogenous amino acid:
synthesized from arginine,
glycine, and methionine)
I/Q
Role in energy metabolism. Responsible for
the production of ATP in skeletal muscle
through the process of oxidative
phosphorylation inside the mitochondria.
Ethanolamine Amines I Widely distributed in biological tissue andis a component of lecithin.
Carnitine
Quaternary ammonium salts
Non-proteinogenic amino
acids
I/Q
Important in providing energy to muscles
Described as a vitamin, an amino acid, or
essential metabolite
Choline Quaternary ammonium salts(Essential Vitamin) I/Q
Considered an essential vitamin.
Precursor for the neurotransmitter
acetylcholine, which is involved in many
functions including memory and
muscle control.
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Table 2. Cont.
Metabolite
Chemical Taxonomy
Subclass
Description
Identified
(I)/Quantified (Q) Function
Lactate
Alpha hydroxy acids and
derivatives
(Energy Substrate)
I/Q
Plays a role in several biochemical
processes and is produced in the muscles
during intense activity
Myoinositol Alcohols and polyols I/Q
Involved in the Inositol phosphate
metabolism and the Phosphatidylinositol
signaling system.
Glucose-1-phosphate
Carbohydrates and
carbohydrate conjugates
(Energy Substrate)
I/Q Glycogenolysis producesglucose-1-phosphate and no energy.
Maltose
Carbohydrates and
carbohydrate conjugates
(Energy Substrate)
I/Q Maltose can be broken down into twoglucose molecules
Glucose
Carbohydrates and
carbohydrate conjugates
(Energy Substrate)
I Primary source of energy
Succinate Dicarboxylic acids andderivatives I/Q
Component of the citric acid or TCA cycle
and is capable of donating electrons to the
electron transfer chain.
Formate Carboxylic acids I
Essential intermediary metabolite in
folate-mediated one-carbon metabolism
Responsible for both metabolic acidosis and
disrupting mitochondrial electron transport
and energy production.
Acetate Carboxylic acid derivates I/Q Acetate in the form of acetyl CoA is used inmetabolism to yield chemical energy.
Acetone Carbonyl compounds I/Q
One of the ketone bodies produced during
ketoacidosis. Since ketosis develops under
serious metabolic circumstances, all the
mechanisms that balance or moderate the
effects of ketosis enhance the chance
for survival.
1 Information detailed on the table was obtained from “The human metabolome database” (http://www.hmdb.ca/).
Table 3. Concentrations of metabolites in bovine oviductal extracellular vesicles according to the stage
of the estrous cycle and the side relative to ovulation (ipsilateral vs. contralateral). Data are given as
means ± SEM of nmoL mg−1 of oEV proteins.
Pre-Ovulatory Post-Ovulatory Mid-Luteal Late-Luteal
Ipsi Contra Ipsi Contra Ipsi Contra Ipsi Contra
Acetate 2.5 ± 0.6 2.8 ± 0.1 2.7 ± 0.2 2.7 ± 0.2 2.9 ± 0.3 2.8 ± 0.0 2.8 ± 0.2 2.8 ± 0.2
Acetone 0.6 ± 0.2 0.7 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 1.0 ± 0.1 0.9 ± 0.0 1.0 ± 0.1 0.9 ± 0.0
Alanine 16.7 ± 3.7 18.1 ± 0.9 15.5 ± 1.6 14.9 ± 1.4 15.5 ± 2.3 13.8 ± 0.3 13.4 ± 0.9 13.8 ± 1.6
Carnitine 4.8 ± 0.8 6.1 ± 0.2 4.3 ± 0.4 4.9 ± 0.6 5.5 ± 0.6 5.7 ± 0.9 5.5 ± 0.8 5.6 ± 0.8
Choline 8.8 ± 1.6 9.4 ± 0.5 10.9 ± 0.9 9.7 ± 0.8 10.3 ± 1.7 10.2 ± 0.4 8.6 ± 0.4 9.5 ± 1.2
Creatine 7.8 ± 1.8 8.4 ± 0.4 7.7 ± 0.6 7.8 ± 0.6 7.9 ± 0.9 7.9 ± 0.5 7.7 ± 0.6 7.7 ± 0.9
Glucose-1-phosphate 1.1 ± 0.6 0.7 ± 0.5 0.8 ± 0.5 3.1 ± 1.5 9.8 ± 2.1 39.5 ± 5.7 87.2 ± 41.8 117.1 ± 1.4
Glycine 25.2 ± 5.0 31.4 ± 5.7 30.8 ± 3.1 25.0 ± 2.1 39.3 ± 6.4 26.5 ± 0.9 27.5 ± 1.8 25.8 ± 4.2
Isoleucine 2.6 ± 0.5 3.2 ± 0.2 2.8 ± 0.3 2.6 ± 0.3 2.7 ± 0.3 2.5 ± 0.0 2.5 ± 0.4 2.4 ± 0.4
Lactate 33.0 ± 6.4 37.7 ± 2.4 36.7 ± 3.1 36.9 ± 2.5 43.0 ± 4.1 41.9 ± 2.7 43.3 ± 6.9 43.7 ± 6.1
Maltose 13.9 ± 5.0 19.1 ± 5.0 14.1 ± 1.7 29.3 ± 10.6 53.2 ± 4.3 110.5 ± 13.1 203.7 ± 9.7 225.1 ± 32.9
Methionine 10.0 ± 1.9 9.8 ± 0.6 8.7 ± 1.0 9.2 ± 1.0 7.3 ± 0.9 7.4 ± 0.6 6.2 ± 0.8 6.4 ± 0.8
Myoinositol 37.6 ± 7.9 41.5 ± 2.2 43.8 ± 4.2 44.4 ± 4.2 50.9 ± 5.5 51.5 ± 3.1 47.8 ± 5.7 50.4 ± 6.2
Succinate 0.7 ± 0.2 0.7 ± 0.0 0.9 ± 0.1 0.8 ± 0.1 1.1 ± 0.1 0.9 ± 0.1 1.0 ± 0.2 0.8 ± 0.2
Valine 3.2 ± 0.8 3.8 ± 0.2 3.3 ± 0.4 3.3 ± 0.4 3.2 ± 0.5 2.9 ± 0.0 2.7 ± 0.2 2.7 ± 0.2
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2.3. Effect of the Stage of the Estrous Cycle and Side of Ovulation on Metabolite Concentrations in oEVs
Principal component analysis of the metabolite levels showed a clear separation of metabolite
profiles between the peri-ovulatory stages (Post-ov and Pre-ov), which clustered together, and the
Mid-lut and Late-lut stages (Figure 2). However, the PCA plot could not discriminate between the two
sides relative to ovulation (ipsilateral vs. contralateral).
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Figure 2. Comparative analysis of the oviduct EV etabolite content across the bovine estrous cycle.
Principal component analysis (PCA) of metabolites measured in oEV at four different stages of the
estrous cycle. S1, post-ovulation (red); S2, mid-luteal phase (blue); S3, late luteal phase (green) and S4,
pre-ovulation (purple) from oviducts ipsilateral (triangles) and contralateral (round spots) to ovulation.
The ANOVA confirmed the results of the multivariate analysis. Except for maltose, which was
slightly affected by the side of ovulation (p = 0.04), there was no difference between the ipsilateral and
contralateral oviducts or cycle stage × side interaction in the concentrations of any metabolite. The
stage of the cycle had a significant effect on the glucose-1-phosphate, maltose, methionine, and acetone
concentrations (Figure 3). Glucose-1-phosphate was the metabolite most affected by the cycle stage,
showing 100-fold higher levels at the luteal phase than at peri-ovulatory phases (p < 0.0001). Similarly,
maltose was on average 8- to 14-fold more concentrated at Late-lut than at Post-ov and Pre-ov in both
sides relative to ovulation (p < 0.0001). In contrast, concentrations of methionine were significantly
higher at Pre-ov and Post-ov than at Late-lut (p < 0.01). In addition, concentrations of acetone were
lower at Pre-ov than at other stages of the cycle (p < 0.01).
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Figure 3. Differential concentrations of specific bovine oEV metabolites across the estrus cycle. Maltose
intra-oEV concentrations (nmol.mg−1 of EV protein, (a) was affected by the cycle stage and side
of ovulation. Glucose-1-P (b), methionine (c) and acetone (d) intra-oEV concentrations were only
influenced by the stage of the estrus cycle. For (b–d), ipsilateral and contralateral concentrations
data were pooled as the side of ovulation did not show any significant effect on the metabolite
level. (Post-ov: post-ovulatory phase; Mid-lut: mid-luteal phase; Late-lut: late lutal phase; Pre-ov:
pre-ovulatory phase).
2.4. Pathways Associated with oEVs Metabolites
The over-representation analysis (ORA) of all identified oEVs metabolites against the pathway
associated metabolite sets of MetaboAnalyst showed that glycine and serine metabolism was the most
significant pathway (p < 0.001 and false discovery rate (FDR) < 0.1; Table 4 and Figure 4).
The quantitative enrichment analysis using the metabolite concentrations at Pre-ov vs. Late-lut
stages is shown in Figure 5. Starch (polysaccharide) and sucrose metabolism, nucleotide sugars
metabolism, glycolysis, lactose synthesis, gluconeogenesis, galactose metabolism, spermidine/spermine
biosynthesis and betaine synthesis were the most regulated pathways between Pre-ov and Late-lut
(p < 0.01 and FDR < 0.1; Table 5). Similar metabolic pathways related to polysaccharide, sucrose,
glucose, and lactose metabolism were significantly regulated by comparing Pre-ov vs. Mid-lut, Post-ov
vs. Mid-lut, a Post-ov vs. Late-lut whereas the Post-ov vs. Pre-ov comparison retrieved no
significant results.
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Table 4. Over representation analysis of all identified metabolites in oEVs against pathway associated
metabolite sets. The associated bar chart visualization of this analysis is shown in Figure 4.
Pathway Associated
Metabolite Sets 1 Implicated Metabolites
2 Total 3 Hits 4 Raw p 5 Holm p 6 FDR 7
Glycine and serine metabolism
Creatine, Glycine, L-glutamic
acid, L-alanine, L-threonine,
L-methionine
59 6 7.82 × 10−4 0.0766 0.0766
Arginine and Proline
Metabolism
Creatine, Glycine, L-glutamic
acid, L-proline, Succinic acid 53 5 0.00332 0.322 0.137
Alanine metabolism Glycine, L-glutamic acid,L-alanine 17 3 0.00421 0.404 0.137
Valine, Leucine and Isoleucine
degradation
L-glutamic acid, L-isoleucine,
Succinic acid, L-leucine,
L-valine
60 5 0.00575 0.546 0.141
Glutathione Metabolism Glycine, L-glutamic acid,L-alanine 21 3 0.0078 0.734 0.146
Carnitine Synthesis L-carnitine, Glycine,Succinic acid 22 3 0.00892 0.829 0.146
Glutamate Metabolism Glycine, L-glutamic acid,L-alanine, Succinic acid 49 4 0.0152 1 0.212
Phosphatidylethanolamine
biosynthesis Choline, Ethanolamine 12 2 0.0234 1 0.267
Ketone Body Metabolism Succinic acid, Acetone 13 2 0.0273 1 0.267
Glucose-Alanine Cycle L-glutamic acid, L-alanine 13 2 0.0273 1 0.267
Phosphatidylcholine
biosynthesis Choline, Ethanolamine 14 2 0.0314 1 0.28
1 Only pathway associated metabolite sets with p < 0.05 are shown in the table; 2 Implicated metabolites from oEVs
in the associated metabolite set; 3 Total number of metabolites in the metabolite set; 4 Hits: number of metabolites
from oEVs involved in the metabolite set; 5 Raw p: original p value calculated from the enrichment analysis; 6 Holm
p: adjusted raw p value by the Holm–Bonferroni method; 7 FDR: false discovery rate.
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Figure 5. Graphical overview of the quantitative enrichment analysis for all metabolites quantified in
bovine oEVs generated by MetaboAnalyst 4.0 web-based software. Pathway associated metabolite sets
are sorted based on fold enrichment and p-value after comparison between stages. This bar chart was
obtained y comparing Pre-ov vs. Late-lut stages. For each stage, ipsilateral and contralateral data were
pooled. Fu ther details on p-values and metabolites included in each pathway are detailed in Table 5.
Table 5. Quantitative enrichment analysis of bovine oEV metabolites against pathway associated
metabolite sets. Associated bar chart visualization of this analysis is shown in Figure 5.
Pathway Associated
Metabolite Sets 1 Implicated Metabolites
2 Total 3 Hits 4 Raw p 5 Holm p 6 FDR 7
Starch and sucrose
metabolism
D-maltose,
Glucose-1-phosphate 31 2 3.21 × 10−5 0.0015 6.835 × 10−4
Nucleotide sugars
metabolism Glucose-1-phosphate 20 1 8.651 × 10−5 0.0039 6.835 × 10−4
Glycolysis Glucose-1-phosphate 25 1 8.651 × 10−5 0.0039 6.835 × 10−4
Lactose synthesis Glucose-1-phosphate 20 1 8.651 × 10−5 0.0039 6.835 × 10−4
Gluconeogenesis Glucos -1-ph sphate, L-lacticacid 35 2 8.662 × 10−5 0.0039 6.835 × 10−4
Galactose metabolism Myoinositol,Glucose-1-phosphate 38 2 8.726 × 10−5 0.1933 6.835 × 10−4
Spermidine and
spermine biosynthesis L-methionine 18 1 0.0047 0.4906 0.032
Betaine metabolism Choline, L-methionine 21 2 0.0123 1 0.072
Methionine metabolism Choline, Glycine, L-methionine 43 3 0.0438 1 1
1 Only pathway associated metabolite sets with p < 0.05 are shown in the table; 2 Implicated metabolites from oEV
in the associ ted metabolite set; 3 Total n mber of metabolites in the metabolite set; 4 Hi s: number of met bolites
from oEV involved in the metabolite set; 5 Raw p: original p value calculated from the enrichment analysis; 6 Holm
p: adjusted raw p value by the Holm–Bonferroni method; 7 FDR: false discovery rate.
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3. Discussion
Currently, there is an increasing number of studies analyzing the metabolomics of EVs in different
biological fluids, since both metabolites and EVs are being considered as valuable biomarkers of health
conditions and play a crucial part in cell-to-cell communications. In the context of pregnancy, oEVs
have been proposed as key modulators of the gametes/embryo-oviduct crosstalk to achieve successful
pregnancy [12]. To the best of our knowledge, this study provides the first metabolic characterization
of oEVs. Furthermore, we demonstrated that the oEV-metabolite cargo is regulated by the hormonal
environment of the estrus cycle, although to a lesser extent than proteins and mRNA in oEVs [5,9].
In the present study, NMR allowed the identification of 22 metabolites in oEVs obtained from cows
at four different stages of the estrus cycle. Among them, various classes of metabolites were found such
as amino acids, vitamins, energy substrates, and others presented in Table 2. Although the amount of
detected metabolites in oEVs was low compared to other metabolomic studies performed by mass
spectrometry methods, NMR was selected because of (1) its advantages in highly selective, quantitative,
and non-destructive analysis [16], and (2) it was the method used to analyze the metabolite composition
of the OF in a previous study performed in our laboratory [15], allowing us a better comparison
between data. In fact, most of the metabolites identified here were previously identified and quantified
in the bovine OF by NMR [15]. Moreover, the predominant metabolites in oEVs (myoinositol, lactate,
and glycine), were also the most abundant metabolites quantified by NMR in the OF by [15]. However,
the less abundant metabolites in the OF (i.e., aspartate, choline, mannose, and pyruvate) were not
detected in the present study. We can speculate that solute metabolites present in the OF cross the
oEV membranes and reach intra-oEV concentrations that mirror those in the OF. Minor metabolites
present in the fluid could remain at undetectable levels after being packed into oEVs. Nevertheless, we
cannot discard the idea that the methodology used in the present study or the starting oEV volume
used limited the detection of those minor metabolites. On the other hand, we identified metabolites
such as maltose and acetone, which had not been previously detected in bovine OF [15]. These results
suggest that these metabolites may be specifically transported from the tubal fluid into oEVs, reaching
higher concentrations inside oEVs than outside. However, the mechanisms by which these metabolites
concentrated into oEVs still remains unknown.
In the present study, besides determining whether the hormonal environment of the estrus cycle
controls the metabolic profile of oEVs, we also aimed to determine if the side related to ovulation
could affect the oEV-metabolite composition, by comparing profiles in ipsilateral versus contralateral
oviducts. We thought it was important to include this factor because (1) in previous work from our
laboratory, we used pools of ipsilateral and contralateral oviducts [5,9], while others have focused only
on the ipsilateral side [17], ignoring the evaluation of the side effect; (2) significant differences in steroid
hormones and protein content in the OF were recorded between the two sides relative to ovulation
in cattle [18,19]. Moreover, the cow, as a mono-ovular species, is an ideal model to study the effect
of the proximity of the ovulatory follicle and post-ovulatory corpus luteum on oviduct physiology.
Nevertheless, our results showed that the abundance of metabolites in oEVs was overall not affected
by the side relative to ovulation. Only the concentration of maltose was slightly different between the
ipsilateral and contralateral oviducts. In the same line, only five metabolites out of the 26 quantified
by NMR in the OF were affected by the side of ovulation, with small differences between ovulation
sides [15]. Other studies in the field of metabolomics have failed to evidence significant differences in
the concentrations of lipids, amino acids, and energy substrates between ipsilateral and contralateral
oviducts [20–24]. The contribution of the pre-ovulatory follicle to the content of the OF after ovulation
has been under debate for many years [14]. However, the similar metabolite composition between both
ovulation sides at Post-ov in oEVs as well as in OF [15], together with other studies above-mentioned
does not support this hypothesis.
As spermatozoa and preimplantation embryos are able to uptake oEVs [5,6,8], oEV-metabolites
at the pre- and post-ovulatory stages may contribute to their continuous supply of amino acids and
energy substrates for the success of early reproductive events. In this sense, we would like to point out
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that the three most abundant metabolites identified in oEVs (i.e., myoinositol, lactate, and glycine,
may have a higher impact on gametes and embryos. Myoinositol and lactate were found to be major
energy substrates in oEVs throughout the estrous cycle. Myoinositol is synthesized from glucose and
is an energy source for both spermatozoa [25] and embryos [26]. Myoinositol improved bovine sperm
motility [27] and embryo development up to the blastocyst stage when added in vitro [28]. Lactate,
together with pyruvate, have been identified as the main energy supply for sperm capacitation [29].
After fertilization, the early pre-implantation embryo uses oxidative metabolism to acquire energy,
mostly from lactate and pyruvate as the main sources of energy [30]. Glycine, a conditionally essential
amino acid, was the third most abundant metabolite in our study and was by far the most abundant
amino acid in the oEVs. Using the ORA program of MetaboAnalyst, several amino acid-associated
pathways, primarily serine and glycine metabolism, were identified as over-represented in oEVs.
Data on the metabolic pathways associated with the establishment of gestation are scarce. However,
glycine is known to be important for early embryo development as it is an essential precursor for the
synthesis of proteins and nucleic acids [31,32]. Moreover, glycine is required for the rapid proliferation
of cells [33]. Glycine also regulates intracellular pH and may have a protecting role against osmotic
stress for preimplantation embryos [34].
Among the metabolites identified, glucose-1-P, maltose, methionine, and acetone displayed
differential concentrations across the estrus cycle, which may reflect the requirements of gamete/embryos
in the oviduct environment. Maltose and glucose-1-phospate, energy substrates in oEVs, were by far
the metabolites most affected by the cycle stage, with 8- to 100-fold higher levels at the luteal phase
than at the pre- and post-ovulatory stages. Most pathways identified in the quantitative enrichment
analysis including starch and sucrose metabolism, nucleotide sugars metabolism, glycolysis, lactose
synthesis, and neoglucogenesis involved one or both of these carbohydrates. The sugar D-maltose is
a glucoside consisting of two glucose monomers connected by an α-1,4-glycosidic bond. Maltose is
usually the product of starch digestion, after alpha-amylase enzymatic action [35]. Although starch is
not present in the oviduct, a large amount of glycogen was reported in the mammalian oviduct, where
it acts as a glucose mobilized reservoir, storing up to 55,000 glucose moieties per molecule [36]. In
the bovine oviduct epithelium, glycogen was quantified at around 60 µg/mg protein [37]. Most of the
glucose residues in glycogen macromolecules are linked by α-1,4-glycosidic bonds while about one
tenth of glucose residues are linked by α-1,6-glycosidic bonds. The enzymes alpha-amylase (AMY2B)
and glycogen phosphorylase (PYGL, liver form and PYGB, brain form), all able to cut α-1,4-linkages,
are produced in oviduct epithelial cells in mammals [30,36] and were reported at high abundance in
the bovine OF [18,38]. Thus, it is likely that maltose and glucose-1-phosphate are products of glycogen
catabolism in the oviduct epithelium. The abundance of maltose and glucose-1-phosphate in oEVs
was upregulated during the luteal phase and reached its highest levels at the Late-lut stage. Similarly,
glucose-1-phosphate in the bovine OF was reported to be 6-fold more abundant during the luteal
phase than at the peri-ovulatory stages [15]. It is of note that levels of maltose and glucose-1-phosphate
in oEVs paralleled those of P4 and were in opposition with those of E2 as previously reported in
the bovine OF [19] and circulating plasma [39]. The hormonal regulation of glycogen metabolism in
the oviduct remains unclear, but reproductive cycle-dependent changes in oviductal glycogen have
been evidenced [36]. In pigs and rabbits, reserves of glycogen in the oviducts were highest near
ovulation and decreased during the following luteal phase [40,41]. Furthermore, the hormonal control
of endometrial glycogen has been well studied in rats, rabbits, and mink, where P4 promotes glycogen
catabolism while E2 stimulates uterine glycogen synthesis and storage [36,42,43]. Altogether, these data
suggest that the products of glycogen catabolism in the oviduct epithelium are abundantly released in
oEVs under P4 action during the luteal phase and that this process is inhibited by E2 during estrus.
The low levels of maltose and glucose-1-phosphate in oEVs during the peri-ovulatory period may play
important roles for the success of reproduction. Interestingly, maltose has been shown to inhibit the
binding of bovine and porcine spermatozoa to oviduct epithelial cell carbohydrates, a process allowing
sperm storage and the delivery of capacitated spermatozoa to the site of fertilization [44,45]. The low
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levels of sources of glucose in oEVs in the post-ovulatory period are also concordant with the fact that
exposure of the early bovine embryo to high amounts of glucose in vitro disturb embryo development
and metabolism [46,47].
Additionally, we found that methionine concentrations in oEVs were higher at Pre-ov and
Post-ov than at Late-lut. Methionine is a precursor for polypeptide synthesis and is an important
factor in the antioxidant balance [48]. Furthermore, due to its role as the immediate precursor of
S-adenosyl methionine, which is the universal methyl donor for epigenetic methylation of DNA and
histones, methionine can influence the epigenetic programming of the embryo [49]. There is evidence
that preimplantation embryo development is vulnerable to disruptions in methionine metabolism.
For instance, disruption of methionine metabolism by ethionine, an antimetabolite of methionine,
impairs the morula-to-blastocyst transition during bovine preimplantation development in vitro [50].
Supplementation of an in vitro embryo culture medium with large doses of S-adenosyl methionine
was reported to cause a shift in bovine embryo sex ratio in favor of males and to induce a genome-wide
hypermethylation [51].
Finally, we would like to discuss the unexpected presence of acetone, although at very low levels
at all stages examined (≤1 nmol/mg of oEV protein), in oEVs. In dairy cows with subclinical or clinical
ketosis, acetone concentrations in the circulating blood may reach 300–350 µmol/L [52,53]. Ketosis (or
acetonemia) is a common disease in high-producing dairy cows caused by a negative energy balance
and occurring mostly within two months after calving. Concentrations of acetone, acetoacetate, and
β-hydroxybutyrate, three ketone bodies, increase in in blood and milk during ketosis [52,53]. This
metabolic picture is typically associated with anestrus and lower fertility in dairy cows [54]. The
ketosis status of the cows used for the present study could not been assessed at the time of oviduct
collection, but they were mostly Holstein dairy cows, commonly regarded as particularly subject to
ketosis. Thus, it is likely that the low concentrations of acetone detected in oEVs reflected low to
moderate levels of acetone in the blood of animals at the time of slaughtering. However, why acetone
levels in oEVs were lower at Pre-ov than at other stages of the estrous cycle is difficult to explain, with
no data available in the current literature to shed some light.
In conclusion, our study provides the first comprehensive metabolomic profile of oEVs. Moreover,
our results show that the hormonal environment of the estrus cycle affects the oEV-metabolite
composition, with significant differences between the peri-ovulatory stages and late-luteal phase for
specific metabolites. Our findings bring new insights into the roles of oEVs in supporting sperm
function, fertilization, and early embryonic development.
4. Materials and Methods
4.1. Collection of Oviductal Fluids
Bovine oviducts were collected at a local slaughterhouse, transported on ice, and classified into
four stages of the estrous cycle based on the ovarian and corpus luteum morphologies, as previously
described [19]: post-ovulatory (Post-ov; Days 1–4 of estrous cycle, coinciding with the time of embryo
presence in the oviduct), mid luteal (Mid-lut; Days 5–11), late luteal (Late-lut; Days 11–17), and
pre-ovulatory (Pre-ov; Days 18–20, coinciding, if inseminated, with the time of sperm capacitation in
the oviduct) (n = 34–54 cows/stage). The OF and epithelial cells were collected from the ipsilateral (to
corpus luteum or Pre-ov follicle) and contralateral oviducts by gentle squeezing with a glass slide.
Mixtures were kept on ice until OF was separated from cells by centrifugation at 2000× g for 15 min.
Then, OF was stored at −80 ◦C until oEV isolation. To avoid the inclusion of cows with cystic follicles
in the Pre-ov group, animals with a Pre-ov follicle larger than 20 mm in diameter were excluded at
the time of oviduct collection. Furthermore, follicular fluid was collected from pre-ovulatory follicles
and assayed for P4 and E2 concentrations by a competitive enzyme-linked immunosorbent assay [55]
and the BioSource E2-EASIA Kit (BioSource, Louvain-la-Neuve, Belgium), respectively. Cows with
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intra-follicular concentrations of P4 higher than 160 ng/mL and of E2 lower than 40 ng/mL were also
excluded, as previously described [19].
4.2. Isolation and Characterization of oEVs
4.2.1. Preparation of Pools Oviductal Fluids and Isolation of oEVs
Preliminary experiments showed that 280 µL of OF was the minimal volume required for the
detection of metabolites in oEVs by NMR. In order to reach at least three samples per estrous cycle
stage and side, and based on the average volume of 30 µL of OF collected per oviduct, a minimum of
34 animals per stage were used (Table 1). To isolate oEVs, OF samples were thawed on ice and 3–4
biological pools were prepared by mixing OF from individual OF samples to reach a final minimum
volume of 280 µL/pool (Table 1). Pools of OF were centrifuged at 12,000× g for 15 min to remove
cellular debris and then ultracentrifuged twice at 100,000 g for 90 min to pellet the oEVs, as previously
described [5]. The oEVs pellets were resuspended in 50 µL PBS, assayed for protein concentration by
BCA (Bicinchoninic Acid) Protein Assay (ThermoFisher, Nanterre, France) and stored at −80 ◦C for
further analysis.
4.2.2. Oviductal EVs Observation by TEM
Aliquots of oEVs samples (one per stage and per side) were fixed with glutaraldehyde 2% for
observation under TEM, as previously described [9]. The micrographs were obtained using TEM
HITACHI HT 7700 Elexience at 80 kV (with a charge-coupled device camera AMT) and JEM 1011
(JEOL, Tokyo, Japan) equipped with a Gatan digital camera driven by Digital Micrograph software
(Gatan, Pleasanton, CA, USA) at 100 kV. The processing of the photos and vesicle size calculation (min
300 vesicles per stage) were carried out by ImageJ software.
4.2.3. Oviductal EVs Characterization by Western Blotting
Proteins (30 µg) were separated by SDS-PAGE and transferred onto nitrocellulose membranes
(Whatman™, GE Healthcare Life Sciences, Amersham, UK). The membranes were blocked with
Tris-buffered saline (TBS) containing Tween 20 (0.5% (w/v)) and supplemented with lyophilized low-fat
milk (5% w/v) for 3 h at room temperature (TBS-T). The membranes were incubated with primary
antibodies diluted in TBS-T containing 5% milk at 4 ◦C with gentle shaking overnight. The primary
antibodies used were directed against CD81 (1:200 dilution; sc-166029, Santa Cruz Biotechnologies,
Heidelberg, Germany), heat shock protein 70 (HSP70, 1:1000; Enzo, ADI-SPA-810), and annexin A1
(ANXA1, 1:400; Santa Cruz Biotechnologies, sc-114387). Subsequently, the membranes were washed
with TBS-T and incubated at room temperature under agitation with secondary antibodies. The
secondary antibodies used were Goat anti Mouse-HRP (1:5000; A4416, Merck, Saint-Quentin-Fallavier,
France) for CD81 and HSP70 and Goat anti Rabbit-HRP (1:5000; A6154, Merck) for ANXA1. Blots
were developed using a mixture of two chemiluminescence substrate developing kit (GE Healthcare
AmershamTH ECL SelectTH Western blotting detection Reagent RPN2235 and Supersignal West Pico
#34087 Chemiluminescent Substrate Thermo Scientific).
4.3. Proton Nuclear Magnetic Resonance Spectroscopy (1H-NMR) Analyses
Samples of oEVs were analyzed by NMR as previously described for bovine OF samples [15].
Briefly, 24 µL of oEV samples were diluted in 172 µL of 0.2 M potassium phosphate buffer in deuterium
oxide (D2O) (pH 7.4 ± 0.5) and 4 µL of 3-(trimethylsilyl) propionic-acid solution at 3.2 mM, used as a
spectrometer field lock signal. The resulting solution was transferred to conventional 3-mm NMR tubes.
Briefly, 1H-NMR spectra were recorded at 298 K on a Bruker Ascend 600 MHz spectrometer (Bruker,
Sadis, Wissembourg, France), equipped with a TCI cryoprobe. Standard NMR spectra were obtained
using a “cpmgpr1d” pulse sequence with a 90◦ pulse, a relaxation delay of 25 s, number of scans of 256
on a time domain of 64 K data points. Data were processed with 0.2 Hz of line broadening for the
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exponential decay function using TopSpin version 3.2 software (Bruker daltonik, Karlshure, Germany).
Metabolite quantifications using the ERETIC peak as a quantitative reference were obtained by the
specific subroutine of the Bruker TopSpin 3.2 program. The ERETIC signal was calibrated on a known
concentration amino-acid solution ([ERETIC] = 198 µM). Spectral assignments were done using the
free version of ChenomX 7.1 software (ChenomX, Edmonton, Canada), in house database, and human
metabolome database (HMDB version 4.0; http://www.hmdb.ca, assessed 18 March 2019) [56]. When
the assignment was uncertain, spiking experiments were used to validate metabolite assignments.
Comparing the NMR spectra obtained from a biological sample spiked-in with a known metabolite
with that obtained without spiking made it possible to confirm or discard the presence or absence of
this metabolite in the biological sample.
4.4. Data Processing and Statistical Analysis of NMR Data
First, the concentration of each metabolite was normalized to 1 mg of oEV protein. Then, to obtain
an overview of the oEV metabolite levels across the different stages of the estrous cycle, principal
component analysis (PCA) was generated using normalized metabolite data in RStudio (R packages:
ggplot2, ggfortify). Statistical analyses were performed using the GraphPad Prism software (version 7,
San Diego, CA, USA). Normalized values were compared between stages of the cycle and sides relative
to ovulation with a two-way analysis of variance (ANOVA) followed by Tukey post-tests. When no
side × stage and side effect (p > 0.05) were identified, data for ipsilateral and contralateral oviducts
were combined and an average value calculated for each stage. A p-value < 0.05 was considered as
significant. Data are presented as means ± SEM.
4.5. Pathway Enrichment Analyses of NMR Data
To investigate the presence of biologically meaningful patterns among the oEV metabolites,
metabolic pathway analysis was performed using the functional enrichment tool of the free web-based
software MetaboAnalyst 4.0 (https://www.metaboanalyst.ca/; assessed 12–24 June 2019) [57]. First,
enrichment over representation analysis (ORA) was performed using the list of all metabolites
identified in oEVs. Then, to obtain further insights on the regulated metabolic pathways across the
cycle, a quantitative enrichment analysis by paired comparisons between stages using normalized
(log transformed) concentrations of quantified metabolites was performed. The p-value and the
false discovery rate (FDR) of each regulated pathway were used to account for significance and false
discovery in the pathway analysis, respectively. In this regard, the thresholds of p-value < 0.05 and
FDR < 0.1 were considered as significant.
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